You are here
Enhancements and Validations in Development
Important: We post our plans for upcoming enhancement and fixes well in advance of their delivery to help system-to-system service providers plan for their own development efforts. We try our best to keep these documents current as our plans evolve. Please keep in mind that these are *draft* documents and are subject to change at any time.
Which opportunities are processed by NIH eRA systems/services?
We process applications posted in Grants.gov under the following Grants.gov agency codes:
FORMS-E ImplementationMost draft documents from the FORMS-E implementation were finalized and moved to our main System-to-System page early in 2018.
In January 2018 we added an ASSIST option for users to pre-populate parts of a human subjects/clinical trials study record from information in ClinicalTrials.gov based on an NCT number provided in field 1.5 of the PHS Human Subjects and Clinical Trials Information form. The following document may still be of interest to folks who want to implement a similar feature within their services.
|Change||Target Date in UAT||Target Date in Production|
Update trigger for the following human subjects validation:
In order to accommodate the special needs of PA-18-936 (Admin Supplements to recover losses due to Harvey/Irma/Maria) we must reduce the severity of the following rules from errors to a warnings to allow for funded extensions beyond the awarded project period.
Reduced to warnings: Oct. 3
Returned to errors: Oct. 24
Remove validations that prevent the use of human subjects exemption codes 7 and 8.
Our ability to make Direct-to-Phase II SBIR awards was recently reinstated. Validations will be adjusted to take advantage of the Direct Phase II checkbox on the FORMS-E SBIR/STTR form.
Additional small business application validations
The RL1 activity code was previously only awarded as a disaggregated piece of a U54 submission, but we plan to accept standalone RL1 applications soon and need to define application processing validations.
The following G08 validations were reduced from errors to warnings and the message was changed to append the text "unless otherwise stated in the opportunity announcement". Will remain warnings until further notice.
New rule 014.6.3 (Progress report publication list is required when a submission is a resubmission of a renewal)
Resubmission of Renewal: Last submission would be a type 2
|New rule 034.8.17 (Provide error for a Study record if response to masking is “Yes”, but Participant, Care Provider Investigator, Outcomes Assessor is not, selected)||Now||Dec. 12|
We expect the page limits and validation messages to be changed for the following rules to accommodate a soon to be announced policy change.
~Jan. 14 for first use for Feb. 11, 2019 due date
Update 11/19/2018: on hold until all approvals are in place
Our authority for the Commercialization Readiness Program was also reinstated. Additional SBIR/STTR validation changes expected.
Known Issues That are Not Yet Scheduled
- Image service - the image created for a single component of a multi-project application currently includes biosketch attachments. In multi-project applications, biosketches are only included as a summary in the full application image and should not display with components. Fix to remove bioseketches from component image is planned, but not yet scheduled. (Fix not yet scheduled)
- Cosmetic issues for preview IER in PHS Human Subjects and Clinical Trials Information form (a few border lines missing) - change to Submission Image Library web service (SIL) needed